10 The AltShock-2 registry from Italy, in 2024, on 657 patients, showed that there is an increasing trend in the use of NIV for patients with cardiogenic shock, regardless of the cause and severity of the condition. 11 This registry revealed that NIV was beneficial even for patients with elevated SCAI stages (C and D).
← all excerpts
Noninvasive Ventilation in Cardiogenic Shock: Reconsidering Contraindications.
1
—
—